William Conway
Analyst · JPMorgan
Let me take that if I can, David and Ken. Carlyle, obviously, values our good name. It's our biggest asset. A lot of times, when our investment professionals or our fundraisers go to see someone, I want them to be able to put their business card down, and it says the Carlyle Group on it, and I want people to really think, well, that's a first-class organization. The thing that we have done, perhaps more in the last few years than in the early years of Carlyle, is now on every investment that we make, we'll have a checklist done on the various CSR issues: labor, the environment, anything, Foreign Corrupt Practices Act. We'll employ far more consultants to do things. Now there's no guarantees. You've got hundreds of portfolio companies, and you've got more than 1,000 people working for Carlyle all over the world. There aren't guarantees, but I think we have done a tremendous amount to try to ensure that we're playing by the rules. And I think, also, we've come to the belief that playing by the rules is good business. It's not bad business. It's good business. It doesn't make it tougher to do business, and it's a good thing. On the Chemring situation, I think that they've been putting out the various releases on the timing. Obviously, at a certain time and at a certain price, we had a certain interest in seeing if a transaction could be put together. Based upon the information we received or the information we didn't receive, we just decided this had gone long enough, and at this time, we're not interested in pursuing it.